2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 34498213 | Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation. | 2021 Sep | 1 |
| 2 | 34885115 | The MEK/ERK/miR-21 Signaling Is Critical in Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer Cells. | 2021 Nov 29 | 2 |